Rabbit Polyclonal Anti-SARS-CoV-2/SARS-CoV Spike Protein Antibody
| Applications | E, WB |
| Reactivities | SARS-CoV, SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | SARS-CoV-2 Spike protein antibody was raised against a peptide corresponding to 17 amino acids within aa 410-460 near the center of SARS-CoV Spike glycoprotein. Predicted reactivity based on immunogen sequence: SARS-CoV-2 Spike protein: (identity 65%, homology 88%). Has been shown to react with SARS-CoV-2 protein (see QC images). |
Rabbit Polyclonal Anti-SARS-CoV-2 Spike Protein Antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV, SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | The antibody was raised against a peptide corresponding to 20 amino acids within the last 50 amino acids of SARS-CoV-2 Spike glycoprotein. Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: 100% |
Rabbit Polyclonal Anti- SARS-CoV-2/SARS-CoV Spike Protein Antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV, SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | The antibody was raised against a peptide corresponding to 16 amino acids between aa 410-460 near the center of SARS-CoV Spike glycoprotein. |
SARS-CoV Spike Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of SARS-CoV Spike. |
| Modifications | Unmodified |
SARS-CoV Spike RBD Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of SARS-CoV Spike RBD. |
| Modifications | Unmodified |
SARS-CoV Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of SARS-CoV Spike S1. |
| Modifications | Unmodified |
Rabbit Polyclonal Anti-SARS-CoV Spike Protein Antibody
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | The antibody was raised against a peptide corresponding to 15 amino acids between aa 650-700 near the center of SARS-CoV Spike glycoprotein. Predicted reactivity based on immunogen sequence to SARS-CoV2 Spike protein unlikely: identity 40%, homology 56%. |
USD 630.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
Rabbit Polyclonal Anti-SARS Matrix Antibody
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | SARS matrix antibody was raised against a synthetic peptide corresponding to 15 amino acids at the carboxy terminus of the SARS matrix protein. |
Rabbit Polyclonal Anti-SARS Envelope Antibody
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | SARS envelope antibody was raised against a synthetic peptide corresponding to amino acids at the carboxy terminus of the SARS envelope protein. |
SARS Spike protein rabbit polyclonal antibody
| Applications | ELISA |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Raised against a synthetic peptide corresponding to amino acids near the center of. SARS Spike glycoprotein. |
SARS Spike protein rabbit polyclonal antibody
| Applications | ELISA |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Raised against a synthetic peptide corresponding to amino acids near the center of. The sARS Spike glycoprotein. |
SARS Spike protein rabbit polyclonal antibody
| Applications | ELISA |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Raised against a synthetic peptide corresponding to amino acids near the center of SARS Spike glycoprotein. |
SARS Spike protein rabbit polyclonal antibody
| Applications | ELISA |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Raised against a synthetic peptide corresponding to amino acids at the carboxy terminus of the SARS Spike glycoprotein. |
Germany
Japan
United Kingdom
China
